Skip to content

Shared Decision Making in Graves Disease - Graves Disease (GD) Choice

Shared Decision Making in Graves Disease - Graves Disease (GD) Choice

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02107794
Enrollment
93
Registered
2014-04-08
Start date
2012-12-31
Completion date
2015-04-30
Last updated
2015-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Graves' Disease, Hyperthyroidism, Thyroid Disease

Keywords

Grave's, Disease, Thyroid, Hyperthyroidism, Thyroidectomy, Radioactive, Iodine, Antithyroid, Shared, Decision, Making, Aid, Evidence, Based, Endocrinology, Mayo, Clinic

Brief summary

The investigators' decision aid for patients with GD, GD Choice, will be the result of a user-centered participatory action research involving) synthesis of the best available evidence from the literature and real-world registry experience, ii) input and involvement of patients, clinicians and other stakeholders, iii) direct observation of encounters and iv) extensive field-testing. The goal is to create a decision aid that will be rigorously evidence-based, clear and complete, able to be used by clinicians with minimal training time, while satisfying extant standards for rigorous high-quality shared decision making tools.

Interventions

OTHERDecision Aid

Paper based decision aid will be utilized to facilitate treatment option conversation between clinician and patient.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults ≥ 18 years * Diagnosis of Graves Disease * Appointment with endocrinologist to discuss treatment options for Graves Disease

Exclusion criteria

* Major barriers to participate in shared decision making or to providing informed consent (i.e. dementia, severe hearing or visual impairment)

Design outcomes

Primary

MeasureTime frameDescription
Decisional Quality (Knowledge, Decisional Conflict, Satisfaction) of 100 participantsup to 2 weeks post-visitOutcome measure to be assessed through post-visit surveys.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026